Skip to content

Hexahydrocannabinol (HHC): pharmacokinetics, systemic toxicity, and acute behavioural effects in Wistar rats.

Klára Šíchová, Barbara Mallarino, Lucie Janeckova, Petr Palivec, Magdaléna Vágnerová, Čestmír Vejmola, Marek Nikolič, Lucie Olejníková, Kristýna Mazochová, Pavel Ryšánek, Martin Šíma, Adam Šafanda, Quang Hiep Bui, Isis Koutrouli, Martin Kuchař, Tomáš Páleníček

October 2, 2024 DOI: 10.22541/au.172786658.80817958/v1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental study
Population Male Wistar rats
Intervention Hexahydrocannabinol (HHC)
Dose 1, 5, and 10 mg/kg
Measures Open field test, Prepulse inhibition of acoustic startle response
Keywords Pharmacokinetics Toxicity Pharmacology
Key findings HHC readily crosses the blood-brain barrier, exhibits mild toxicity, and produces behavioral effects similar to THC-like cannabinoids.

Abstract

Background and

Purpose: Hexahydrocannabinol (HHC) is a novel psychoactive substance that has gained attention due to its psychotropic effects and temporary legal status. It is widely abused in several EU and US countries, where it serves as a legal and easily accessible alternative to ∆ 9 -tetrahydrocannabinol (∆ 9 -THC). Despite its widespread use, few studies have examined its in vivo effects and safety profile. Experimental approach: This study investigated the pharmacokinetics, systemic toxicity, and acute behavioural effects of HHC in male Wistar rats. A mixture of (9 R )-HHC and (9 S )-HHC epimers (in a 1:1 ratio) was administered via intragastric gavage at doses of 1, 5, and 10 mg/kg. Behavioural effects were assessed using the Open field test and the Prepulse inhibition of acoustic startle response. Key

Results: Two hours after 10 mg/kg administration, concentrations of both HHC epimers peaked in blood serum and brain tissue. According to the OECD 423 toxicity test, HHC was classified as a Category 4 substance, with an estimated lethal dose of 1000 mg/kg. Compared to the control group (administered sunflower oil), the highest dose (10 mg/kg) led to reduced locomotor activity, increased anxiety, and impaired sensorimotor gating. Conclusions &

Implications: HHC readily crosses the blood-brain barrier, exhibits mild toxicity, and produces behavioural effects similar to THC-like cannabinoids.